Mehta, Rashi I.
Carpenter, Jeffrey S.
Mehta, Rupal I.
Haut, Marc W.
Wang, Peng
Ranjan, Manish
Najib, Umer
D’Haese, Pierre-François
Rezai, Ali R.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability
https://doi.org/10.1080/17425247.2019.1567490
Ultrasound-mediated blood–brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer’s disease
https://doi.org/10.1186/s12987-023-00447-y
Article History
Received: 4 December 2022
Accepted: 31 May 2023
First Online: 16 June 2023
Declarations
:
: This study protocol was approved by the U.S. Food and Drug Administration and the West Virginia University institutional review board.
: Informed consent was obtained from each participant at the time of enrollment into the trial.
: The authors declare that they have no competing interests.